These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12810421)

  • 21. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS).
    Dixey J; Solymossy C; Young A;
    J Rheumatol Suppl; 2004 Mar; 69():48-54. PubMed ID: 15053454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.
    Krause D; Gabriel B; Herborn G; Braun J; Rau R
    Clin Exp Rheumatol; 2015; 33(5):611-6. PubMed ID: 26315962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
    Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
    Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab in active early rheumatoid arthritis.
    Breedveld FC; Emery P; Keystone E; Patel K; Furst DE; Kalden JR; St Clair EW; Weisman M; Smolen J; Lipsky PE; Maini RN
    Ann Rheum Dis; 2004 Feb; 63(2):149-55. PubMed ID: 14722203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).
    van der Heijde DM; van Leeuwen MA; van Riel PL; van de Putte LB
    J Rheumatol; 1995 Sep; 22(9):1792-6. PubMed ID: 8523365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE; Voulgari PV; Alamanos Y; Drosos AA
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Gladman DD
    Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
    Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
    Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K; Matsuno T
    Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.
    van Nies JA; van Steenbergen HW; Krabben A; Stomp W; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
    Ann Rheum Dis; 2015 May; 74(5):883-9. PubMed ID: 24431393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    J Rheumatol; 2003 Apr; 30(4):705-13. PubMed ID: 12672187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
    Meyer O; Labarre C; Dougados M; Goupille P; Cantagrel A; Dubois A; Nicaise-Roland P; Sibilia J; Combe B
    Ann Rheum Dis; 2003 Feb; 62(2):120-6. PubMed ID: 12525380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic markers of radiographic progression in early rheumatoid arthritis.
    Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
    Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study.
    Prodanovic SZ; Radunovic G; Babic D; Ristic B; Sefik-Bukilica M; Zlatanovic M; Simic-Pasalic K; Seric S; Vujasinovic-Stupar N; Samardzic J; Damjanov N
    Med Princ Pract; 2018; 27(4):378-386. PubMed ID: 29794470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
    Brahe CH; Dehlendorff C; Østergaard M; Johansen JS; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard H; Hansen I; Lottenburger T; Jacobsen S; Jurik AG; Hetland ML
    Scand J Rheumatol; 2018 Jul; 47(4):259-269. PubMed ID: 29336711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.